A Journey to Reach the Ovary Using Next-Generation Technologies.

ABSTRACT: Although effective in terms of the chances of future live birth, the current methods for fertility preservation, such as oocyte, embryo, or ovarian tissue cryopreservation, cannot be offered to all cancer patients in all clinical contexts. Expanding options for fertility preservation is crucial to addressing the need to encompass all situations. One emerging strategy is pharmacoprotection, a non-invasive approach that has the potential to fill existing gaps in fertility preservation. In addition to the identification of the most effective therapeutic agents, the potential for off-target effects remains one of the main limitations of this strategy for clinical application, particularly when healthy ovarian tissue is targeted. This review focuses on the advances in pharmacoprotective approac

SUBMITTER: Nguyen TTA 

PROVIDER: S-EPMC10705884 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature